Topics

HTL ups GMP production capacity of injectable-grade sodium hyaluronate

04:39 EST 8 Nov 2019 | Manufacturing Chemist

The French facility will multiply HTL Biotechnology’s injectable-grade sodium hyaluronate production capacity by 2.5 times by 2021

Original Article: HTL ups GMP production capacity of injectable-grade sodium hyaluronate

NEXT ARTICLE

More From BioPortfolio on "HTL ups GMP production capacity of injectable-grade sodium hyaluronate"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...